IR@PKUHSC  > 北京大学临床肿瘤学院  > 肿瘤放疗科
学科主题临床医学
Long-Term Clinical Outcome of Intensity-Modulated Radiotherapy for Inoperable Non-Small Cell Lung Cancer: The MD Anderson Experience
Jiang, Zhi-Qin5; Yang, Kunyu6; Komaki, Ritsuko; Wei, Xiong; Tucker, Susan L.3; Zhuang, Yan2; Martel, Mary K.2; Vedam, Sastray2; Balter, Peter2; Zhu, Guangying7; Gomez, Daniel; Lu, Charles4; Mohan, Radhe2; Cox, James D.; Liao, Zhongxing1
关键词Non-small-cell Lung Cancer Imrt Early And Late Toxicity Radiation-induced Toxicity
刊名INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2012-05-01
DOI10.1016/j.ijrobp.2011.06.1963
83期:1页:332-339
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Radiology, Nuclear Medicine & Medical Imaging
研究领域[WOS]Oncology ; Radiology, Nuclear Medicine & Medical Imaging
关键词[WOS]3-DIMENSIONAL CONFORMAL RADIOTHERAPY ; TREATMENT-RELATED PNEUMONITIS ; CONCURRENT CHEMOTHERAPY ; SEQUENTIAL CHEMORADIOTHERAPY ; DOSE-ESCALATION ; TARGET VOLUME ; RADIATION ; TOXICITY
英文摘要

Purpose: In 2007, we published our initial experience in treating inoperable non-small-cell lung cancer (NSCLC) with intensity-modulated radiation therapy (IMRT). The current report is an update of that experience with long-term follow-up.

Methods and Materials: Patients in this retrospective review were 165 patients who began definitive radiotherapy, with or without chemotherapy, for newly diagnosed, pathologically confirmed NSCLC to a dose of >= 60 Gy from 2005 to 2006. Early and late toxicities assessed included treatment-related pneumonitis (TRP), pulmonary fibrosis, esophagitis, and esophageal stricture, scored mainly according to the Common Terminology Criteria for Adverse Events 3.0. Other variables monitored were radiation-associated dermatitis and changes in body weight and Karnofsky performance status. The Kaplan-Meier method was used to compute survival and freedom from radiation-related acute and late toxicities as a function of time.

Results: Most patients (89%) had Stage III to IV disease. The median radiation dose was 66 Gy given in 33 fractions (range, 60-76 Gy, 1.8-2.3 Gy per fraction). Median overall survival time was 1.8 years; the 2-year and 3-year overall survival rates were 46% and 30%. Rates of Grade >= 3 maximum TRP (TRPmax) were 11% at 6 months and 14% at 12 months. At 18 months, 86% of patients had developed Grade >= 1 maximum pulmonary fibrosis (pulmonary fibrosis(max)) and 7% Grade >= 2 pulmonary fibrosis(max). The median times to maximum esophagitis (esophagitis(max)) were 3 weeks (range, 1-13 weeks) for Grade 2 and 6 weeks (range, 3-13 weeks) for Grade 3. A higher percentage of patients who experienced Grade 3 esophagitismax later developed Grade 2 to 3 esophageal stricture.

Conclusions: In our experience, using IMRT to treat NSCLC leads to low rates of pulmonary and esophageal toxicity, and favorable clinical outcomes in terms of survival. (C) 2012 Elsevier Inc.

语种英语
WOS记录号WOS:000302993900069
引用统计
被引频次:70[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/55209
专题北京大学临床肿瘤学院_肿瘤放疗科
作者单位1.Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Unit 97, Houston, TX 77030 USA
2.Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA
3.Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
4.Univ Texas MD Anderson Canc Ctr, Dept Thorac Med Oncol, Houston, TX 77030 USA
5.Fudan Univ Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China
6.Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan 430074, Peoples R China
7.Peking Univ Sch Oncol, Beiijng Canc Hosp & Inst, Dept Radiat Oncol, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Jiang, Zhi-Qin,Yang, Kunyu,Komaki, Ritsuko,et al. Long-Term Clinical Outcome of Intensity-Modulated Radiotherapy for Inoperable Non-Small Cell Lung Cancer: The MD Anderson Experience[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,2012,83(1):332-339.
APA Jiang, Zhi-Qin.,Yang, Kunyu.,Komaki, Ritsuko.,Wei, Xiong.,Tucker, Susan L..,...&Liao, Zhongxing.(2012).Long-Term Clinical Outcome of Intensity-Modulated Radiotherapy for Inoperable Non-Small Cell Lung Cancer: The MD Anderson Experience.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,83(1),332-339.
MLA Jiang, Zhi-Qin,et al."Long-Term Clinical Outcome of Intensity-Modulated Radiotherapy for Inoperable Non-Small Cell Lung Cancer: The MD Anderson Experience".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 83.1(2012):332-339.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Jiang, Zhi-Qin]的文章
[Yang, Kunyu]的文章
[Komaki, Ritsuko]的文章
百度学术
百度学术中相似的文章
[Jiang, Zhi-Qin]的文章
[Yang, Kunyu]的文章
[Komaki, Ritsuko]的文章
必应学术
必应学术中相似的文章
[Jiang, Zhi-Qin]的文章
[Yang, Kunyu]的文章
[Komaki, Ritsuko]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。